Purchase Order 75N92020P00066
Award Date 2/1/20
Potential Completion Date 1/31/25
Potential Value $148K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson And Company (BD) on January 10, 2020 for the maintenance of a BD Fortessa flow cytometer analyzer. The contract has a potential value of $223,064.40 and a completion date of January 12, 2025. The place of performance is Bethesda, Maryland. BD is a global medical technology company that provides a...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $64,908 firm fixed price purchase order to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for maintenance services for the CantoiI flow cytometer analyzer. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide maintenance services for the flow cytometer located in Bethesda, Maryland...
- This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
- This is a firm fixed-price service contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the maintenance of a Fortessa X-20 flow cytometry instrument. The contract period is from August 18, 2017, to August 17, 2018, with a ceiling value of $24,047.88. BD, a global medical technology company, is the prime contractor for this contract, which does not have a small business...
- On January 13, 2025, the National Heart Lung and Blood Institute (NHLBI) awarded a firm fixed-price purchase order valued at $51,828.84 to Becton, Dickinson and Company's BD Biosciences division for maintenance services on a Fortessa flow cytometer analyzer. The contract, designated as part of the FY26 UDO Initiative, has an ultimate completion date of January 12, 2026, and will be performed in San Jose, California. This award requires no small business set-aside and represents a child...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
- Becton, Dickinson and Company's BD Biosciences division was awarded a $201,042 firm fixed-price purchase order by the National Heart Lung and Blood Institute (NHLBI) on April 1, 2025, for the Service Agreement Symphony A3 and Lasers. The contract, which operates without a small business set-aside, has an ultimate completion date of March 31, 2030, and will be performed in Bethesda, Maryland. Based on BD Biosciences' established federal contract portfolio, this award likely encompasses...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $53,205.12 to Becton, Dickinson and Company (BD Biosciences) on January 1, 2026, for maintenance coverage of its LSRFortessa flow cytometry system and throughput sampler. This firm fixed-price contract, which serves as a child delivery order under a larger indefinite delivery vehicle, will be performed in San Jose, California and is scheduled for completion by December 31, 2026. The award was made without...
- This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on the LSR Fortessa equipment located in the NHLBI Division of Intramural Research (DIR). The contract has a period of performance of one year with four optional one-year extension periods, for a total potential value of $203,688. The contract does not have a set-aside...
- The National Heart Lung and Blood Institute (NHLBI) awarded a purchase order to Becton, Dickinson and Company's BD Biosciences division for continued operation and maintenance services of a BD Fortessa flow cytometer (Serial No. H647794L5026) at its Pulmonary Critical Care Branch facility in Bethesda, Maryland. The contract, valued at $118,943.64 under firm fixed pricing, supports the instrument's state-of-the-art capabilities for assessing fluorescent probes in biomedical research applications....